Local and systemic effects of a silver nitrate coated indwelling pleural catheter in an animal model of pleurodesis

被引:6
|
作者
Tremblay, Alain [1 ]
Kearney, Christine T. [2 ]
Hanks, Chris [3 ]
Hanks, Jennifer Hughes [3 ]
White, David S. [3 ]
Pereira, Marcia E. [4 ]
Zook, Craig E. [4 ]
Sargis, Karen [2 ]
Zhang, Luke [3 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada
[2] Becton Dickinson & Co Inc, Vernon hills, IL USA
[3] Sinclair Res Ctr LLC, Auxvasse, MO USA
[4] Histosci Res Labs Inc, Mt Jackson, VA USA
关键词
cancer; pleurodesis; pleural effusion; silver nitrate; SPONTANEOUS PNEUMOTHORAX; MANAGEMENT; EFFICACY; SAFETY;
D O I
10.1080/01902148.2017.1384865
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose/Aim of the study: This study assessed the safety and potential toxicity of a silver nitrate coated indwelling pleural catheter (SNCIPC) designed to create pleurodesis in a large animal model. Materials andMethods: Sixteen animals underwent insertion of either a SNCIPC or an uncoated silicone catheter. Half of the animals were sacrificed at day 7 and the others at day 30. Animal weight and assessment ofwell-being, pleural fluid and blood collectionwere performed at regular intervals. Pleurodesis was assessed at necropsy and histopathological examination of organs performed. Results: No mortality or significant clinical findingswere observed throughout the experiment. SNCIPC treated animals had increased pleural fluid drainage overall (p < 0.001) and specifically on days 1-4. No differences in hemoglobin, white blood cell count or neutrophil countswere detected between groups. No treatment related histological findings were observed in any of the evaluated tissues outside of the treated area. Serum silver levels in SNCIPC catheter treated animals peaked on Day 4 (0.185 mu g/mL, 30 day group) then gradually decreased for the remainder of the study period. The highest tissue silver concentrationswere noted in the SNCIPC groups in tissues close to the treatment site in addition to the liver (59.8ug/g +/-8.6 and 73.3ug/g +/-25). Pleurodesis scores were significantly higher in SNCIPC treated animals for both the 7 day (median 6.5 vs. 1.0, p = 0.029) and 30 day cohorts (median 7.0 vs. 1.5, p= 0.029). Conclusions: SNCIPC arewell tolerated and not associated with any significant signs of toxicity. Silver levels were elevated in local tissues, serum and liver but without evidence of pathological impact. Effective pleurodesis was present by day 7 and more established by day 30. Clinical studies to investigate the safety and efficacy of this device in patients with malignant pleural effusions appear warranted.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 50 条
  • [31] A Novel Mouse Model Of Malignant Pleural Effusion With Indwelling Pleural Catheter
    Merrick, C.
    Sherrill, T.
    Psallidas, I.
    Maldonado, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] AUSTRALASIAN MALIGNANT PLEURAL EFFUSION ( AMPLE)1 RANDOMIZED CONTROLLED TRIAL OF INDWELLING PLEURAL CATHETER VERSUS TALC PLEURODESIS
    Lee, Y.
    Fysh, E.
    Smith, N.
    Lee, P.
    Kwan, B.
    Yap, E.
    Horwood, F.
    Piccolo, F.
    Lam, D.
    Garske, L.
    Shrestha, R.
    Kosky, C.
    Read, C.
    Murray, K.
    Thomas, R.
    RESPIROLOGY, 2018, 23 : 41 - 41
  • [33] INDWELLING PLEURAL CATHETER VERSUS TALC PLEURODESIS IN ADULTS WITH MALIGNANT PLEURAL EFFUSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Bonello, S.
    McCafferty, J.
    THORAX, 2018, 73 : A80 - A81
  • [34] Prognostic biochemical biomarkers to predict response to pleurodesis or indwelling pleural catheter for malignant pleural effusion- a scoping review
    Ahmadzai, Sina
    Porcel, Jose M.
    Mei, Federico
    Bodtger, Uffe
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [35] Novel mouse model of indwelling pleural catheter in mice with malignant pleural effusion
    Merrick, Christopher
    Sherrill, Taylor
    Kanellakis, Nikolaos I.
    Asciak, Rachelle
    Stathopoulos, Georgios T.
    Maldonado, Fabien
    Rahman, Najib M.
    Blackwell, Timothy
    Psallidas, Ioannis
    ERJ OPEN RESEARCH, 2019, 5 (02)
  • [36] Australasian Malignant Pleural Effusion (ample) Trial: A Multicentre Randomised Study Comparing Indwelling Pleural Catheter Versus Talc Pleurodesis
    Lee, Y. G.
    Fysh, E. T. H.
    Thomas, R.
    Smith, N. A.
    Lee, P.
    Kwan, B. C. H.
    Yap, E.
    Horwood, F. C.
    Piccolo, F.
    Lam, D. C. L.
    Garske, L. A.
    Shrestha, R.
    Kosky, C.
    Read, C. A.
    Murray, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [37] MALIGNANT SOLITARY FIBROUS TUMOR OF PLEURA WITH RAPIDLY REACCUMULATING PLEURAL EFFUSION: FIRST REPORT OF PLEUROSCOPY, PLEURODESIS, AND INDWELLING PLEURAL CATHETER
    Razia, Deepika
    Murray, Carmold
    Zaidi, Wali
    Deanda, Selina
    Ali, Emaan
    Khokar, Abid i
    Saeed, Ali i
    CHEST, 2024, 166 (04) : 4566A - 4567A
  • [38] COMPARING THE QUALITY OF LIFE AND COST-EFFECTIVENESS OF INDWELLING PLEURAL CATHETER VS. TALC PLEURODESIS FOR MALIGNANT PLEURAL EFFUSIONS
    Penz, E.
    Mishra, E.
    Davies, H.
    Manns, B.
    Miller, R. F.
    Rahman, N.
    THORAX, 2013, 68 : A42 - A43
  • [39] Low doses of silver nitrate induce pleurodesis with a limited systemic response
    Marchi, Evaldo
    Vargas, Francisco S.
    Acencio, Milena M. P.
    Antonangelo, Leila
    Teixeira, Lisete R.
    Light, Richard W.
    RESPIROLOGY, 2009, 14 (06) : 885 - 889
  • [40] Talc pleurodesis via chest drain vs indwelling pleural catheter (IPC) for managing malignant pleural effusions in a district general hospital
    Adizie, J. B.
    Harrison, S.
    Huntley, C.
    Sivakumar, N.
    Morgan, A.
    LUNG CANCER, 2016, 91 : S10 - S10